VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,000 | -68.8% | 200 | -52.4% | 0.00% | -50.0% |
| Q1 2022 | $16,000 | +14.3% | 420 | -4.3% | 0.00% | 0.0% |
| Q4 2021 | $14,000 | +7.7% | 439 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $13,000 | -13.3% | 439 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $15,000 | +7.1% | 439 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $14,000 | -12.5% | 439 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $16,000 | -5.9% | 439 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $17,000 | +142.9% | 439 | +119.5% | 0.00% | +100.0% |
| Q2 2020 | $7,000 | +40.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $5,000 | -16.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $6,000 | -50.0% | 200 | -54.2% | 0.00% | -50.0% |
| Q3 2019 | $12,000 | +9.1% | 437 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $11,000 | +175.0% | 437 | +118.5% | 0.00% | +100.0% |
| Q1 2019 | $4,000 | -81.8% | 200 | -79.8% | 0.00% | -75.0% |
| Q1 2018 | $22,000 | – | 988 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |